PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today issued its fourth annual Environmental, Social, and Governance (ESG) report. This year's report highlights the strength of the Company's corporate responsibility structure including increased efforts towards transparency in our environmental reporting, our deep commitment to ensuring broad an ...